ABA. Banerjea

A. Banerjea

*This is an algorithmically generated author record based on publicly available information.

A. Banerjea has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • M. P. Powar

    SpR General Surgery, Kent Surrey and Sussex Region, UK

    1 shared publication
  • R. E. Hands

    Centre for Academic Surgery, The Royal London Hospital, Bart’s and the London Queen Mary School of Medicine and Dentistry, London

    1 shared publication
  • S. Dorudi

    Centre for Academic Surgery, The Royal London Hospital, Bart’s and the London Queen Mary School of Medicine and Dentistry, London

    1 shared publication
  • Stephen Andrew Bustin

    Medical Technology Research Centre, Faculty of Health, Education, Medicine and Social Care, Anglia Ruskin University, Chelmsford CM1 1SQ, UK

    1 shared publication

Latest Publications

  • Microsatellite and chromosomal stable colorectal cancers demonstrate poor immunogenicity and early disease recurrence

    by A. Banerjea, R. E. Hands, M. P. Powar, S. A. Bustin, S. Dorudi

    Objective Colorectal cancers may demonstrate chromosomal instability (CSI) or microsatellite instability (MSI‐H). A third group of microsatellite and chromosome stable (MACS) colorectal cancer has been described more recently. Patients with MSI‐H colorectal cancers demonstrate improved outcome and a pronounced inflammatory infiltrate. Enhanced host immune response and increased immunogenicity might explain these observations. This study aims to further characterize colorectal cancer immunogenicity. Method Microsatellite stability status was determined in resected tumour samples. Microsatellite stable (MSS) tumour samples were stratified by DNA ploidy status, as determined by flow cytometry into aneuploid MSS (CSI) and diploid MSS (MACS) cancers. Lymphocyte proliferation, quantified by bromodeoxyuridine incorporation assays assessed tumour protein immunogenicity and ELISA assays quantified inflammatory cytokine release. Kaplan–Meier survival curves and multivariate analyses were used to determine prognostic value. Results Patients with MSI‐H colorectal cancer had improved outcome but those with MACS cancers undergoing curative surgery had significantly poorer disease‐free survival (P = 0.002). The MACS phenotype was an independent predictor of poor outcome (HR = 2.44, 1.33–4.47, P = 0.004). Lymphocyte proliferation assays confirmed enhanced immunogenicity of MSI‐H proteins and reduced immunogenicity of MACS proteins (P < 0.0001). In vitro levels of IFN‐γ (P = 0.004) and IL‐18 (P < 0.0001) mirrored these differences in lymphocyte activity. Conclusions Stratification of colorectal cancer by MSI and ploidy status may have prognostic value in patients undergoing curative surgery. MSI‐H cancers display enhanced immunogenic properties but the immune response to MACS cancers appears to be absent and this may contribute to their poor prognosis.